TY - JOUR
T1 - Rewiring of regenerated axons by combining treadmill training with semaphorin3A inhibition
AU - Zhang, Liang
AU - Kaneko, Shinjiro
AU - Kikuchi, Kaoru
AU - Sano, Akihiko
AU - Maeda, Miho
AU - Kishino, Akiyoshi
AU - Shibata, Shinsuke
AU - Mukaino, Masahiko
AU - Toyama, Yoshiaki
AU - Liu, Meigen
AU - Kimura, Toru
AU - Okano, Hideyuki
AU - Nakamura, Masaya
N1 - Funding Information:
We thank Kiyokazu Iwata, Toshihiro Nagai and Takahiro Kondo for sample preparation and all members of the Okano laboratory for helpful discussions and support. This work was supported by grants from the Project for the Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports and Technology (MEXT) of Japan and the Research Center Network for the Realization of Regenerative Medicine to H.O. and M.N.; a grant for young investigators from MEXT to S.K.; a grant from the General Insurance Association of Japan to L.Z., S.K. and M.N. and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) to H.O.
PY - 2014/3/10
Y1 - 2014/3/10
N2 - Background: Rats exhibit extremely limited motor function recovery after total transection of the spinal cord (SCT). We previously reported that SM-216289, a semaphorin3A inhibitor, enhanced axon regeneration and motor function recovery in SCT adult rats. However, these effects were limited because most regenerated axons likely do not connect to the right targets. Thus, rebuilding the appropriate connections for regenerated axons may enhance recovery. In this study, we combined semaphorin3A inhibitor treatment with extensive treadmill training to determine whether combined treatment would further enhance the "rewiring" of regenerated axons. In this study, which aimed for clinical applicability, we administered a newly developed, potent semaphorin3A inhibitor, SM-345431 (Vinaxanthone), using a novel drug delivery system that enables continuous drug delivery over the period of the experiment. Results: Treatment with SM-345431 using this delivery system enhanced axon regeneration and produced significant, but limited, hindlimb motor function recovery. Although extensive treadmill training combined with SM-345431 administration did not further improve axon regeneration, hindlimb motor performance was restored, as evidenced by the significant improvement in the execution of plantar steps on a treadmill. In contrast, control SCT rats could not execute plantar steps at any point during the experimental period. Further analyses suggested that this strategy reinforced the wiring of central pattern generators in lumbar spinal circuits, which, in turn, led to enhanced motor function recovery (especially in extensor muscles). Conclusions: This study highlights the importance of combining treatments that promote axon regeneration with specific and appropriate rehabilitations that promote rewiring for the treatment of spinal cord injury.
AB - Background: Rats exhibit extremely limited motor function recovery after total transection of the spinal cord (SCT). We previously reported that SM-216289, a semaphorin3A inhibitor, enhanced axon regeneration and motor function recovery in SCT adult rats. However, these effects were limited because most regenerated axons likely do not connect to the right targets. Thus, rebuilding the appropriate connections for regenerated axons may enhance recovery. In this study, we combined semaphorin3A inhibitor treatment with extensive treadmill training to determine whether combined treatment would further enhance the "rewiring" of regenerated axons. In this study, which aimed for clinical applicability, we administered a newly developed, potent semaphorin3A inhibitor, SM-345431 (Vinaxanthone), using a novel drug delivery system that enables continuous drug delivery over the period of the experiment. Results: Treatment with SM-345431 using this delivery system enhanced axon regeneration and produced significant, but limited, hindlimb motor function recovery. Although extensive treadmill training combined with SM-345431 administration did not further improve axon regeneration, hindlimb motor performance was restored, as evidenced by the significant improvement in the execution of plantar steps on a treadmill. In contrast, control SCT rats could not execute plantar steps at any point during the experimental period. Further analyses suggested that this strategy reinforced the wiring of central pattern generators in lumbar spinal circuits, which, in turn, led to enhanced motor function recovery (especially in extensor muscles). Conclusions: This study highlights the importance of combining treatments that promote axon regeneration with specific and appropriate rehabilitations that promote rewiring for the treatment of spinal cord injury.
KW - Axonal regeneration
KW - Drug delivery system
KW - Inhibitor
KW - Rehabilitation
KW - Rewiring
KW - Semaphorin3A
UR - http://www.scopus.com/inward/record.url?scp=84898015012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898015012&partnerID=8YFLogxK
U2 - 10.1186/1756-6606-7-14
DO - 10.1186/1756-6606-7-14
M3 - Article
C2 - 24618249
AN - SCOPUS:84898015012
SN - 1756-6606
VL - 7
JO - Molecular brain
JF - Molecular brain
IS - 1
M1 - 14
ER -